FDA Approved: TREMFYA — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TREMFYA (guselkumab) submitted by Janssen Biotech, Inc., affecting the drug's approved labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

SUPPL AP for TREMFYA (GUSELKUMAB)